Blood Sugar

FDA rule offers only narrow field for blood sugar management claims, experts say

Special Edition: Blood Sugar Management

FDA rule offers only narrow field for blood sugar management claims, experts say

By Hank Schultz

As obesity rates worldwide continue to rise and the related scourge of diabetes increases in lockstep, companies marketing ingredients in the United States intended to help consumers who find themselves sliding somewhere along this curve toward a full...

Hope in rejection: “The outcome actually says there may well be a physiological effect of Teestar, however they need a more detailed clinical study.”

“We do not see this as a rejection.”

EFSA refuses fenugreek for glycaemic benefits

By Shane STARLING

A 9-study dossier linking herbal extract fenugreek (Trigonella foenum-graecum L.) and improved glycaemic response has been deemed insufficient by the EU’s central science agency. But the firm’s chief told us, “We do not see this as a rejection.”

New class of ‘good’ fat could aid diabetes prevention

New class of ‘good’ fat could aid diabetes prevention

By Nathan Gray

The ‘surprising’ discovery of a previously unidentified class of lipid molecules that enhance insulin sensitivity and blood sugar control could offer a route to the prevention of type 2 diabetes, say researchers.

Vitabiotics has complied with the ASA ruling for its Diabetone food supplement

UK ASA ruling

UK on diabetic supplement: Blood sugar link ok (but not diabetes)

By Shane STARLING

The brand name of a food supplement aimed at diabetics called Diabetone is protected under the EU nutrition and health claim regulation (NHCR), the UK advertising watchdog has found. But it ruled against what it found to be text suggestive of treatment.

Jaime Schwartz: 'For those diagnosed with prediabetes, the first line of defense in preventing diabetes is to lose weight, not to eat specially formulated products'

Special edition: Tackling diabetes. Formulating for healthy blood sugar

How can the food industry address the ticking time bomb of type 2 diabetes?

By Elaine WATSON

Given that one in three American adults is expected to develop type 2 diabetes by 2050, and poor diet and lack of exercise may be largely to blame, what can food and beverage manufacturers do to tackle this epidemic?

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers